跳至主要内容
临床试验/NCT01264588
NCT01264588已完成不适用

A Randomized, Single Blind, Comparative, Controlled Study On The Effects Of Topical Calcium Glycerophosphate On Surgical Wound Healing And Residual Scarring In Bilateral Total Knee Arthroplasty Patients

AkPharma Inc.2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2008年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AkPharma Inc.
入组人数
20
试验地点
2
主要终点
Improvement of surgical wound appearance

研究概览

简要总结

The purpose of this study is to determine whether topical application of calcium glycerophosphate will result in superior wound appearance and scar minimization.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Investigator)

入排标准

年龄范围
45 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Informed consent must be obtained
  • 45-75 years of age
  • Scheduled for bilateral knee replacement surgery

排除标准

  • Employee or immediate family of either AkPharma or employee or immediate family of investigator or site personnel
  • Pregnant or breast feeding Known allergy or hypersensitivity to calcium or phosphorus supplements
  • Diagnosed with type I or type II diabetes mellitus

结局指标

主要结局

Improvement of surgical wound appearance

时间窗: Post-Op Day: 3 (baseline), 7, 14, 42, 70, 98, 180, 365

Digital photographs as objective measurements are taken at each time point, and evaluated by an Expert Grader, blinded as to treatment vs. control, for any differences in the time required for wound closure and/ or scar minimization between treated and untreated groups.

次要结局

  • Reduction of visible erythema/ inflammation(Post-Op Day: 3 (baseline), 7, 14, 42, 70, 98, 180, 365)
  • Scar minimization or prevention(Post-Op Day: 3 (baseline), 7, 14, 42, 70, 98, 180, 365)
  • Incision/ scar pain and sensitivity(Post-Op Day: 3 (baseline), 7, 14, 42, 70, 98, 180, 365)
  • Range of motion(Post-Op Day: 3 (baseline), 7, 42, 180, 365)

研究者

发起方
AkPharma Inc.
申办方类型
Industry

研究点 (2)

Loading locations...

相似试验